Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

Opinion | Why comparing Covid-19 vaccine efficacy numbers can be misleading

10 Mar, 2021 | 08:31h | UTC

Why comparing Covid-19 vaccine efficacy numbers can be misleading – Vox

 

Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

10 Mar, 2021 | 08:36h | UTC

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster – The Lancet

Original study and news release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval

 

Opinion | The Differences Between the Vaccines Matter

10 Mar, 2021 | 08:33h | UTC

The Differences Between the Vaccines Matter – Vox

 

A pandemic expert weighs in on the long road ahead for Covid-19 vaccine distribution

10 Mar, 2021 | 08:35h | UTC

A pandemic expert weighs in on the long road ahead for Covid-19 vaccine distribution – STAT

 

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

10 Mar, 2021 | 08:29h | UTC

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome – JAMA Neurology

 

Commentary on Twitter

 

RCT: 5 days of high-dose amoxicillin therapy noninferior to 10 days for the treatment of pediatric community-acquired pneumonia

9 Mar, 2021 | 02:29h | UTC

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics (free for a limited period)

Editorial: Rightsizing Treatment for Pneumonia in Children

Commentary: Five days of antibiotics fine for children with pneumonia – McMaster University

 

Commentary on Twitter (thread – click for more)

 

New CDC Guideline for fully vaccinated individuals says people can get together indoors without masks. Precautions should continue in public.

9 Mar, 2021 | 02:56h | UTC

Guideline: Interim Public Health Recommendations for Fully Vaccinated People– Centers for Disease Control and Prevention

See also: When You’ve Been Fully Vaccinated: How to Protect Yourself and Others – Centers for Disease Control and Prevention

Commentaries: You’re fully vaccinated? The CDC says you can now have friends and family over for dinner – Vox AND CDC says fully vaccinated Americans can spend time together indoors and unmasked – STAT AND CDC Says It’s Safe For Vaccinated People To Do These Activities – WBUR AND If you got the COVID-19 vaccine, here’s what the CDC says you can do – Live Science

 

Report: Risk of death from Covid-19 significantly increased in countries where most are overweight

9 Mar, 2021 | 02:52h | UTC

Report: COVID-19 and Obesity: The 2021 Atlas

Commentaries: Covid-19 death rates 10 times higher in countries where most adults are overweight, report finds – CNN AND Covid-19: Highest death rates seen in countries with most overweight populations – The BMJ AND Covid-19: We must tackle obesity and health inequalities in order to build back better – The BMJ Opinion AND COVID-19 Death Rates 10 Times Higher in Countries Where Most Are Overweight – HealthDay

 

CDC study: Body mass index and risk for COVID-19–related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death

9 Mar, 2021 | 02:54h | UTC

Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: CDC: Obese adults at higher risk for hospitalization, death from COVID-19 – UPI AND Obesity a Big Risk Factor for Severe COVID-19, Study Confirms – HealthDay

 

Colchicine and COVID-19: a Tale of Two Trials

9 Mar, 2021 | 02:51h | UTC

Colchicine and COVID-19: a Tale of Two Trials – CVCT CardioBrief

Study 1: RECOVERY trial: Colchicine arm stopped for lack of efficacy in patients hospitalized with COVID-19

Study 2: [Preprint] Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

 

New study of Coronavirus variants predicts virus evolving to escape current vaccines, treatments

9 Mar, 2021 | 02:49h | UTC

News release: New Study of Coronavirus Variants Predicts Virus Evolving to Escape Current Vaccines, Treatments – Columbia University Irving Medical Center

Original study: Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 – Nature

 

Commentary on Twitter

 

Editorial | Avoiding exploitation in multinational covid-19 vaccine trials

9 Mar, 2021 | 02:43h | UTC

Avoiding exploitation in multinational covid-19 vaccine trials – The BMJ

 

Study confirms higher transmissibility of SARS-CoV-2 lineage B.1.1.7

9 Mar, 2021 | 02:47h | UTC

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England – Science

Commentary: Study confirms B.1.1.7 variant of SARS-CoV-2 is more transmissible – News Medical

 

Commentary on Twitter (thread – click for more)

 

[Preprint] Systematic review: Characteristics of SARS-CoV-2 reinfection vs. persistent COVID-19

9 Mar, 2021 | 02:44h | UTC

SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection – medRxiv

Commentary: How can physicians distinguish between COVID-19 persistence and SARS-CoV-2 reinfection? – News Medical

 

Ten things to consider when implementing rationing guidelines during a pandemic

9 Mar, 2021 | 02:46h | UTC

Ten things to consider when implementing rationing guidelines during a pandemic – Intensive Care Medicine

 

Commentary on Twitter

 

Few pro athletes had inflammatory heart disease after COVID

9 Mar, 2021 | 02:41h | UTC

Few pro athletes had inflammatory heart disease after COVID – CIDRAP

Original study: Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening – JAMA Cardiology

 

RECOVERY trial: Colchicine arm stopped for lack of efficacy in patients hospitalized with COVID-19

7 Mar, 2021 | 20:16h | UTC

RECOVERY trial closes recruitment to colchicine treatment for patients hospitalised with COVID-19 – University of Oxford

Commentary: Cochicine does not improve mortality in COVID19 – St Emlyn’s

 

Commentary on Twitter

 

RCT: Azithromycin provides no benefit for community treatment of patients with suspected COVID-19

7 Mar, 2021 | 20:15h | UTC

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet

 

Commentary on Twitter

 

WHO: The effects of virus variants on COVID-19 vaccines

7 Mar, 2021 | 20:09h | UTC

The effects of virus variants on COVID-19 vaccines – World Health Organization

 

Mask mandates and restaurant restrictions tied to fewer Covid-19 illnesses and deaths, CDC study says

7 Mar, 2021 | 20:07h | UTC

Mask mandates and restaurant restrictions tied to fewer Covid-19 illnesses and deaths, CDC study says – CNN

Original study: Association of State-Issued Mask Mandates and Allowing On-Premises Restaurant Dining with County-Level COVID-19 Case and Death Growth Rates — United States, March 1–December 31, 2020 – CDC Morbidity and Mortality Weekly Report

 

Commentary on Twitter

 

[Preprint] Genomics and epidemiology of a novel SARS-CoV-2 lineage P.1 – “P.1 may be 1.4–2.2 times more transmissible and 25-61% more likely to evade protective immunity elicited by previous infection with non-P.1 lineages”

7 Mar, 2021 | 20:05h | UTC

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil – medRxiv

Commentary: Brazil variant can reinfect virus survivors; COVID-19 vaccine antibodies pass into breast milk – Reuters

 

[Preprint] SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

7 Mar, 2021 | 19:53h | UTC

Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization – bioRxiv

Commentary: Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization – News Medical

 

[Medicine based on data leaks…] Oxford study indicates AstraZeneca vaccine is effective against SARS-CoV-2 Lineage P.1

7 Mar, 2021 | 19:48h | UTC

Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says – Reuters

 

Commentary on Twitter

https://twitter.com/hildabast/status/1368010132781600773

 

[Preprint] Preliminary study shows Sinovac vaccine may not trigger sufficient antibody response to SARS-CoV-2 Lineage P.1

7 Mar, 2021 | 19:49h | UTC

Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination – The Lancet

Commentary: Sinovac vaccine may not trigger sufficient antibody response to Brazil variant: study – Reuters

 

Commentary on Twitter

 

[Preprint] Increased risk of hospitalization associated with infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark

7 Mar, 2021 | 19:46h | UTC

Increased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark – The Lancet

 

Commentary on Twitter (thread – click for more)

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.